
Hologic, Inc.
HOLX
Updated: 22/09/2026, 18:02:52
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.
No summaries found.
- Share price
- $76.01
- Market cap
- $16.97B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Paul Malenchini
- Employees
- 7,063
- IPO date
- 01/03/1990
- Beta
- 0.703
- Last dividend
- $0.00
- Day range
- $76.01 – $76.01
- 52-week range
- $51.90 – $76.07
- 1-day performance
- 0.00%
- 1-year performance
- 46.45%
- Current drawdown (1Y)
- -0.08%
- CIK
- 0000859737
- CUSIP
- 436440101
- ISIN
- US4364401012
- Created
- 07/12/2025, 04:34:45
- Last update
- 22/09/2026, 18:02:52
Track Hologic, Inc. with an AI analyst
See which prediction-market events move HOLX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
New Evidence Backs Hologic's AI-Powered Mammography Technology for Detecting Challenging Cancers
Business Wire • STOCK • 20/04/2026, 10:05:00
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research • STOCK • 31/03/2026, 12:01:46
HOLX vs. ALGN: Which MedTech Stock Is the Better Investment Pick Now?
Zacks Investment Research • STOCK • 25/03/2026, 10:32:18
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Zacks Investment Research • STOCK • 20/03/2026, 11:01:30
Hologic's Women's Health Index Flags Alarming Gaps in STI Screening
Zacks Investment Research • STOCK • 19/03/2026, 11:15:20
Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase?
Zacks Investment Research • STOCK • 18/03/2026, 11:31:30
What Drives Hologic's GYN Surgical Strength in a Competitive Market?
Zacks Investment Research • STOCK • 10/03/2026, 10:40:45
Hologic's Diagnostics Strength in Focus: Is More Upside Ahead?
Zacks Investment Research • STOCK • 06/03/2026, 11:55:34
HOLX vs. GEHC: Which Women's Health Stock Should You Pick Now?
Zacks Investment Research • STOCK • 26/02/2026, 13:16:06
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio
Business Wire • STOCK • 04/02/2026, 09:15:00